Finanzwire Finanzwire
Basculer en Français
10679 Companies
227991 Keywords
156500 Articles
120868 Press releases
Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG Remove
  1. Home
  2. Companies
  3. Secarna Pharmaceuticals GmbH & Co. KG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/03/2023 at 18:05, 2 years 8 months ago

    Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/25/2023 at 15:00, 2 years 8 months ago

    Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/17/2023 at 14:00, 2 years 8 months ago

    Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 07/06/2023 at 14:00, 2 years 11 months ago

    Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 06/05/2023 at 14:00, 3 years ago

    Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 03/27/2023 at 16:04, 3 years 3 months ago

    Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
Previous page
1 ... 3 4
Accesswire
  • Published on 07/03/2026 at 21:28, 1 hour 33 minutes ago

    Trifecta Gold Announces Closing of $1.66 Million Private Placement

  • Published on 07/03/2026 at 19:30, 3 hours 31 minutes ago

    Polaris Renewable Energy Announces Q2 2026 Investor Call Details

  • Published on 07/03/2026 at 13:30, 9 hours 31 minutes ago

    Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

  • Published on 07/03/2026 at 13:30, 9 hours 31 minutes ago

    Guanajuato Silver Announces AGM Results

  • Published on 07/03/2026 at 00:45, 22 hours 16 minutes ago

    FireFox Gold Finalizes Finders Fees on Recent Offering

View all ACCESSWIRE
EQS Group
  • Published on 07/03/2026 at 18:55, 4 hours 5 minutes ago

    Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development

  • Published on 07/03/2026 at 18:14, 4 hours 46 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 07/03/2026 at 18:00, 5 hours 1 minute ago

    Charwood Energy: W&nergy, a subsidiary of Charwood Energy, is launching a €2 million crowdfunding campaign on Enerfip.

  • Published on 07/03/2026 at 18:00, 5 hours 1 minute ago

    Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors

  • Published on 07/03/2026 at 17:41, 5 hours 19 minutes ago

    AGRANA Annual General Meeting votes for a dividend of €0.35

View all EQS
Les Echos
  • Published on 07/03/2026 at 21:49, 1 hour 11 minutes ago

    Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.

  • Published on 07/03/2026 at 18:42, 4 hours 18 minutes ago

    Total number of voting rights and shares making up the share capital at June 30, 2026

  • Published on 07/03/2026 at 18:36, 4 hours 24 minutes ago

    Disclosure of transactions in own shares from July 1 to July 3, 2026

  • Published on 07/03/2026 at 18:00, 5 hours 1 minute ago

    Half-year liquidity contract statement June 30, 2026

  • Published on 07/03/2026 at 17:54, 5 hours 7 minutes ago

    Mersen: Number of shares and voting rights as of June 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy